Author

Honglei Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

An Energy-Sustainable and Oxidative-Tolerant Nanofactory of Therapeutic Proteins for Long-Acting Therapy of Inflammatory Bowel Disease.

A nanozyme-augmented energy-sustainable and oxidative-tolerant nanofactory of therapeutic proteins (NENFpro) has been developed, which represents a desirabl strategy for the in situ long-acting therapy of chronic IBD.

Qian Chen, Lenan Xu, Ke Duan et al. · ACS Nano · 0 citations